tat/rev/nef-rt
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00083603)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tat/rev/nef-rt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00107549 | Phase 1 | Apr 5, 2005 | Duke University, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) |
| NCT00083603 | Phase 1 | Sep 1, 2004 | National Institute of Allergy and Infectious Diseases (NIAID), St. Louis University, University of Rochester |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 2 | 1 | 2004 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2005 |
| St. Louis University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Rochester | Academic/Hospital | 1 | 0 | 1 | 2004 |
5 organizations
Page 1 / 1